These authors then developed a novel gene signature, comprised of PER1, RORA, REV-ERBA, and the additional clock genes NPAS2 and TIMELESS, which independently predicted prognosis in patients with HCC [83]. This evidence concerns the gene RORA and hepatocellular carcinoma.